At Mewburn Ellis we work with organisations building the brands and technologies that will define tomorrow. We help them use their intellectual property to navigate that journey - to imagine, plan, nurture, protect and deliver their innovations to market.
We are offering to manage the process of converting all pending EU trade mark applications into UK trade mark applications for new and existing clients for free.Find out more
We are offering to manage the process of converting all pending EU trade mark applications into UK trade mark applications for new and existing clients for free.
A wealth of experience working with UK and overseas corporate clients of all sizes, in all industry sectorsFind out more
A genuine understanding of the IP needs and commercial goals of start-up and spin-out companiesFind out more
Excellent, long-standing relationships with many lawyers and IP attorneys from all over the worldFind out more
Clear, straightforward, commercial advice that will help achieve your business objectivesFind out more
Unrivaled patent expertise in all technologies to ensure R&D can be translated into real business benefitsFind out more
Commercial trade mark advice covering all aspects of IP for your brands across all jurisdictionsFind out more
We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.Find out more
Massive social, economic and technology trends are converging to change mobility - how we move things from point A to point B, be they people, goods or containers. All of these drivers of change are self-reinforcing. We are at the start of a period of profound change: the ways by which we travel and move things will be very different from what exists in most of the world today. This is a revolution that will touch every corner of our lives.Find out more
New genomic and proteomic analysis technologies allow for diagnosis and prognosis of patients with greater accuracy than ever before. Indeed, due to the substantial amount of research now undertaken in this space, we are now able to identify new disease states and conditions previously unknown or poorly understood, allowing early detection and treatment of disease.Find out more